
CardioNerds Cardiac Critical Care Knowledge Hub
Welcome to the Cardiac Critical Care Knowledge Hub, powered by CardioNerds and created by cardiologists. In this series, we deliver key information on the diseases and treatment options most relevant to the modern cardiac intensive care unit.
Advertisement
An article discussing the complex interplay between mechanical ventilation and cardiopulmonary mechanics.
Despite advances in treatment, cardiogenic shock (CS) outcomes remain dire. As such, researchers initiated the ...
The American Heart Association (AHA) recently created the Cardiogenic Shock Registry to enhance the quality of care and ...
Experts discuss the basics of mechanical ventilation and a framework for outlining the goals of mechanical ventilation.
The CardioNerds cover an overview of valvular shock, including nuances in diagnosis, differing presentations, and more.
The CardioNerds evaluate three separate admissions for a single patient to highlight pearls regarding waveform assessment.
Advertisement
More From the CardioNerds
Ticagrelor monotherapy after dual-antiplatelet therapy following PCI with DES yields superior outcomes.
Dr. Clark details the MINT trial, which addressed the accurate transfusion threshold in patients with acute MI and anemia.
Dr. Okumus details the ORBITA-2 trial, which marked a significant advancement in understanding and treating stable angina.
CardioNerds correspondent Dr. Ahmed Ghoneem details the positive effects of semaglutide, as demonstrated in the SELECT trial.
CardioNerds correspondent Dr. Christian Inchaustegui details the findings of ARIES-HM3, presented at AHA 2023.
In low-risk patients with symptomatic AS, TAVR is safe, effective, and durable up to 5 years.